Defining the Syrian hamster as a highly susceptible preclinical model for SARS-CoV-2 infection

Authors

Kyle Rosenke, National Institutes of Health
Kimberly Meade-White, National Institutes of Health
Michael Letko, National Institutes of Health
Chad Clancy, National Institutes of Health
Frederick Hansen, National Institutes of Health
Yanan Liu, Utah State University
Atsushi Okumura, National Institutes of Health
Tsing Lee Tang-Huau, National Institutes of Health
Rong Li, Utah State University
Greg Saturday, National Institutes of Health
F Feldmann
Dana Scott, National Institutes of Health
Zhongde Wang, Utah State University
Vincent Munster, National Institutes of Health
Michael A. Jarvis, School of Biomedical Sciences
H Feldmann

ORCID

• Michael A. Jarvis: 0000-0002-0124-4061

DOI

10.1080/22221751.2020.1858177

Publication Date

2020-12-25

Publication Title

Emerging Microbes & Infections

Volume

9

Issue

1

Embargo Period

2021-08-11

First Page

2673

Last Page

2684

Recommended Citation

Rosenke, K., Meade-White, K., Letko, M., Clancy, C., Hansen, F., Liu, Y., Okumura, A., Tang-Huau, T., Li, R., Saturday, G., Feldmann, F., Scott, D., Wang, Z., Munster, V., Jarvis, M., & Feldmann, H. (2020) 'Defining the Syrian hamster as a highly susceptible preclinical model for SARS-CoV-2 infection', Emerging Microbes & Infections, 9(1), pp. 2673-2684. Available at: 10.1080/22221751.2020.1858177